www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

Anti-PD-1 (Camrelizumab), Humanized Antibody

Supplier:
Catalogue number:
A2132-100
Size:
100 µg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£607.00 Estimated delivery Wed 30 Jun
Shipping is calculated in checkout

Camrelizumab (AiRuiKa™) is a humanised monoclonal IgG4 anti-PD-1 monoclonal antibody developed by Jiangsu Hengrui Medicine Co. Ltd for the treatment of various solid and hematological malignancies. Upon administration, the antibody blocks the binding of PD-1 to its ligands PD-L1 and PD-L2. This inhibits PD-1 downstream signaling and restores normal immune function by activating cytotoxic T lymphocytes and T cell-mediated immune responses against cancer cells. Currently, Camrelizumab is being investigated for treatment of advanced hepatocellular carcinoma (HCC), non-small cell lung cancer (NSCLC) and Hodgkin lymphoma

Product Type:

Antibodies

Storage Temp:

4°C

Antibody Host:

CHO cells

Antibody Isotype:

Human IgG4

Formulation:

In PBS, pH 7.2

Antibody Type:

Monoclonal

UNSPSC Code:

12352203

Details Cat number & supplier Size Price
Anti-PD-1 (Spartalizumab), Humanized Antibody A2131-100 · BioVision
A2131-100
BioVision
100 µg £607.00
100 µg
view
Anti-IL-6Rα (Sarilumab), Human IgG1 Antibody A2133-100 · BioVision
A2133-100
BioVision
100 µg £607.00
100 µg
view
Anti-PGAM1 Rabbit Monoclonal Antibody A2130-100 · BioVision
A2130-100
BioVision
100 µl £435.00
100 µl
view
Anti-G6PD Rabbit Monoclonal Antibody A2134-100 · BioVision
A2134-100
BioVision
100 µl £435.00
100 µl
view
Anti-ROCK2 Rabbit Monoclonal Antibody A2129-100 · BioVision
A2129-100
BioVision
100 µl £479.00
100 µl
view
Anti-CCR8 Rabbit Monoclonal Antibody A2135-100 · BioVision
A2135-100
BioVision
100 µl £435.00
100 µl
view
Anti-SHP2 Rabbit Monoclonal Antibody A2128-100 · BioVision
A2128-100
BioVision
100 µl £441.00
100 µl
view